Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3

Jutta Gärtner1, Tanuja Chitnis2, Angelo Ghezzi3

  • 1Department of Pediatrics and Adolescent Medicine, German Centre for Multiple Sclerosis in Childhood and Adolescence, University Medical Center Göttingen, Germany.

Abstract

Insights

Young adults with multiple sclerosis (MS) experience higher disease activity. Fingolimod treatment significantly reduced relapses and new lesions, showing greater benefits in younger patients compared to the general MS population.

Area of Science:

  • Neurology
  • Immunology
  • Clinical Trials

Background:

  • Multiple sclerosis (MS) exhibits distinct disease activity patterns in young adults compared to the general adult population.
  • Understanding these differences is crucial for effective treatment strategies.

Purpose of the Study:

  • To assess the efficacy of fingolimod 0.5 mg in managing disease activity in young adults with MS.
  • Evaluate treatment effects across different age strata within the young adult demographic.

Main Methods:

  • Analysis of data from three randomized, double-blind Phase 3 trials.
  • Comparison of annualized relapse rate (ARR), new/enlarging T2 lesions (neT2), and no evidence of disease activity (NEDA-3) between age groups and treatment arms.
  • Statistical modeling using negative binomial and logistic regression, with age as a covariate.

Main Results:

  • Younger patients exhibited higher ARR, which was significantly reduced by fingolimod.
  • Fingolimod demonstrated a significant reduction in neT2 lesions across most age groups compared to placebo or interferon beta-1a (IFN β-1a).
  • Fingolimod treatment led to higher rates of NEDA-3 achievement, with the most pronounced benefits observed in the youngest patients.

Conclusions:

  • Young adults with MS present with elevated disease activity.
  • Fingolimod treatment offers significant benefits for young adults with MS, potentially exceeding those seen in the overall adult population.

Related Concept Videos

ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH301:11

orthopara-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3

All ortho–para directors, excluding halogens, are activating groups. These groups donate electrons to the ring, making the ring carbons electron-rich. Consequently, the reactivity of the aromatic ring towards electrophilic substitution increases. For instance, the nitration of anisole is about 10,000 times faster than the nitration of benzene. The electron-donating effect of the methoxy group in anisole activates the ortho and para positions on the ring and stabilizes the corresponding...
7.5K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
429
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.8K
Phase Transitions: Sublimation and Deposition02:33

Phase Transitions: Sublimation and Deposition

Some solids can transition directly into the gaseous state, bypassing the liquid state, via a process known as sublimation. At room temperature and standard pressure, a piece of dry ice (solid CO2) sublimes, appearing to gradually disappear without ever forming any liquid. Snow and ice sublimate at temperatures below the melting point of water, a slow process that may be accelerated by winds and the reduced atmospheric pressures at high altitudes. When solid iodine is warmed, the solid sublimes...
20.3K